A systematic review of research on radiomics and deep learning for adrenal mass evaluation suggests these technologies could help doctors better distinguish between different types of adrenal tumors. The review looked at studies using these techniques to differentiate pheochromocytomas, paragangliomas, adrenal cortical adenomas, and adrenal cortical carcinomas. The findings indicate that radiomics and deep learning can extract high-dimensional features from medical images and enable automated analysis, potentially improving diagnostic precision.
However, this is not a clinical trial. The review is a summary of existing research, and the evidence is still early. The authors note that there are technical limitations and barriers to translating these tools into everyday clinical practice. No specific numbers on accuracy or patient outcomes were reported.
For now, these techniques remain promising but not ready for widespread use. Patients with adrenal masses should continue to follow standard diagnostic and treatment recommendations from their doctors. This research provides a theoretical foundation for future development of intelligent adrenal mass evaluation systems.